Cure My Disease

Don't miss your cure!

 Log in / Sign up

A new way to gauge balance training intensity in MS?

NCT ID NCT07805850

Symptom relief Sponsor: Klinik Valens Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 04, 2026 · Last updated Sep 04, 2026

Summary

This study tests whether balance training tailored to each person's difficulty level is feasible for people with multiple sclerosis during a three-week inpatient rehabilitation stay. Participants are randomly assigned to either standard group training or individually tailored balance training, with sessions three times per week. Researchers measure balance, mobility, fatigue, and cognitive function before and after, and interview patients and therapists about their experiences. The goal is to see if this personalized approach can be practically implemented and whether it might improve balance and walking.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Individually tailored balance training with intensity guided by perceived stability
What this could lead to
If feasible, this approach could give therapists a clear method to set the right challenge level in balance training, potentially improving gait and mobility for people with MS.
What could go wrong
This is a small feasibility study, not a proof of effectiveness. The training may not produce measurable improvements, and results may not apply beyond the inpatient rehab setting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with a definite MS diagnosis according to 2024 revised McDonald criteria; * Hold an Expanded disability status (EDSS) between 2.0-6.5; * An inpatient stay of at least three weeks at the ; * Aged 18 years and older; * Have sufficient knowledge of the German language (spoken and written). Exclusion Criteria: * Cognitive impairment indicated by a score of \<21 on the Montreal Cognitive Assessment (MoCA); * Severe osteoporosis; * Fractures and/or other surgical interventions; * Presence of any other condition that would substantially influence balance; * Alcoholism; * Participation in another study; * Pregnancy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Balance are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Balance Multiple sclerosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Rehabilitation Centre Valens

    RECRUITING

    Valens, Canton of St. Gallen, 7317, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.